Novare Capital Management LLC Abbott Laboratories Transaction History

Novare Capital Management LLC

  • $1.16 Billion
  • Q3 2024

A detailed history of Novare Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Novare Capital Management LLC holds 106,549 shares of ABT stock, worth $12.2 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
106,549
Previous 105,115 1.36%
Holding current value
$12.2 Million
Previous $10.9 Million 11.22%
% of portfolio
1.04%
Previous 0.99%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$100.07 - $118.13 $143,500 - $169,398
1,434 Added 1.36%
106,549 $12.1 Million
Q2 2024

Aug 01, 2024
SELL
$100.73 - $112.44 $102,341 - $114,239
-1,016 Reduced 0.96%
105,115 $10.9 Million
Q1 2024

May 06, 2024
BUY
$109.52 - $120.96 $258,795 - $285,828
2,363 Added 2.28%
106,131 $12.1 Million
Q4 2023

Feb 08, 2024
BUY
$90.19 - $110.4 $547,723 - $670,459
6,073 Added 6.22%
103,768 $11.4 Million
Q3 2023

Nov 02, 2023
BUY
$95.53 - $114.62 $194,308 - $233,137
2,034 Added 2.13%
97,695 $9.46 Million
Q2 2023

Jul 28, 2023
BUY
$100.78 - $112.29 $88,585 - $98,702
879 Added 0.93%
95,661 $10.4 Million
Q1 2023

Apr 20, 2023
SELL
$96.86 - $114.01 $34,772 - $40,929
-359 Reduced 0.38%
94,782 $9.6 Million
Q4 2022

Jan 17, 2023
BUY
$95.06 - $111.52 $5,133 - $6,022
54 Added 0.06%
95,141 $0
Q3 2022

Oct 11, 2022
BUY
$96.76 - $112.03 $160,331 - $185,633
1,657 Added 1.77%
95,087 $9.2 Million
Q2 2022

Aug 03, 2022
BUY
$102.07 - $123.37 $90,127 - $108,935
883 Added 0.95%
93,430 $10.2 Million
Q1 2022

May 09, 2022
SELL
$114.02 - $139.04 $278,322 - $339,396
-2,441 Reduced 2.57%
92,547 $11 Million
Q4 2021

Feb 03, 2022
BUY
$115.53 - $141.46 $94,619 - $115,855
819 Added 0.87%
94,988 $13.4 Million
Q3 2021

Nov 04, 2021
BUY
$116.66 - $129.06 $35,581 - $39,363
305 Added 0.32%
94,169 $11.1 Million
Q2 2021

Aug 02, 2021
BUY
$105.79 - $124.53 $266,167 - $313,317
2,516 Added 2.75%
93,864 $10.9 Million
Q1 2021

May 11, 2021
BUY
$108.84 - $128.23 $209,190 - $246,458
1,922 Added 2.15%
91,348 $10.9 Million
Q4 2020

Feb 01, 2021
SELL
$105.0 - $114.42 $344,610 - $375,526
-3,282 Reduced 3.54%
89,426 $9.79 Million
Q3 2020

Nov 03, 2020
SELL
$91.64 - $111.29 $183,554 - $222,913
-2,003 Reduced 2.11%
92,708 $10.1 Million
Q2 2020

Aug 06, 2020
SELL
$76.57 - $98.0 $321,976 - $412,090
-4,205 Reduced 4.25%
94,711 $8.66 Million
Q1 2020

May 05, 2020
SELL
$62.82 - $91.86 $65,332 - $95,534
-1,040 Reduced 1.04%
98,916 $7.81 Million
Q4 2019

Feb 06, 2020
BUY
$78.51 - $87.4 $126,401 - $140,714
1,610 Added 1.64%
99,956 $8.68 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $253,949 - $275,360
-3,103 Reduced 3.06%
98,346 $8.23 Million
Q2 2019

Aug 08, 2019
SELL
$72.88 - $85.0 $161,210 - $188,020
-2,212 Reduced 2.13%
101,449 $8.53 Million
Q1 2019

May 09, 2019
SELL
$66.22 - $80.06 $265,542 - $321,040
-4,010 Reduced 3.72%
103,661 $8.29 Million
Q4 2018

Feb 12, 2019
SELL
$65.56 - $74.27 $91,784 - $103,978
-1,400 Reduced 1.28%
107,671 $7.79 Million
Q3 2018

Nov 09, 2018
BUY
$60.81 - $73.36 $2,736 - $3,301
45 Added 0.04%
109,071 $8 Million
Q2 2018

Aug 10, 2018
BUY
$57.57 - $63.54 $63,327 - $69,894
1,100 Added 1.02%
109,026 $6.65 Million
Q1 2018

May 09, 2018
BUY
$56.27 - $63.62 $91,776 - $103,764
1,631 Added 1.53%
107,926 $6.47 Million
Q4 2017

Feb 06, 2018
BUY
$53.68 - $57.47 $243,331 - $260,511
4,533 Added 4.45%
106,295 $6.07 Million
Q3 2017

Nov 07, 2017
BUY
$48.06 - $53.64 $4.89 Million - $5.46 Million
101,762
101,762 $5.43 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email